Mastercard Incorporated Third-Quarter Financial Results Available on Company’s Website

PURCHASE, N.Y.--(BUSINESS WIRE)-- Mastercard Incorporated (NYSE: MA) today announced its financial results for its third quarter of 2019 through an earnings release available on the company’s Investor Relations website at investor.mastercard.com. The earnings release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K and available here.

At 9:00 a.m. ET today, the company will host a conference call to discuss these financial results.

Conference Call Details:

U.S. dial-in: 833-236-5755

International dial-in (outside the U.S.): 647-689-4183

A replay of the call will be available for 30 days and can be accessed by dialing 800-585-8367 (within the U.S.) and

416-621-4642 (outside the U.S.), using passcode 3496343.

A webcast for this call and all related materials can also be accessed at investor.mastercard.com.

About Mastercard Incorporated

Mastercard (NYSE: MA), www.mastercard.com, is a technology company in the global payments industry. Our global payments processing network connects consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. Mastercard products and solutions make everyday commerce activities - such as shopping, traveling, running a business and managing finances - easier, more secure and more efficient for everyone. Follow us on Twitter @MastercardNews, join the discussion on the Beyond the Transaction Blog and subscribe for the latest news on the Engagement Bureau.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005613/en/

Investor Relations: Warren Kneeshaw or Gina Accordino, [email protected], 914-249-4565
Communications: Seth Eisen, [email protected], 914-249-3153

Source: Mastercard Investor Relations

You May Also Be Interested In

• NVE Corporation names new CEO and expands board to seven members
• FDA backs Entera Bio's Phase 3 trial plan for oral osteoporosis drug
• Dyne Therapeutics adds Barry Greene to its board of directors